ABALLI JOHN (President and CEO) sold 4.3% of their position (31.79K shares) of EXAGEN INC. on the open market
Open‑market sale worth $375.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/20/2025ACC: 0001843113-25-000003
DirectorOfficer· President and CEO
Since Mar 2026
-31.79K
Net shares
Net seller
$375.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
31.79K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−31.79K
Price / share
$11.82
Trade value
$375.60K
% of position
4.3%
10/16/2025
746.21K→714.43K
Total
Net shares
−31.79K
Net value
-$375.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/16/2025 | S · Sale | −31.79K | $11.82 | $375.60K | 4.3% | 746.21K | 714.43K |
| Total | −31.79K | -$375.60K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned40.40K
Total
40.40K indirect40.40K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 40.40K | Indirect |
| Total | 40.40K | 40.40K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported